A Form 4 filed with the SEC on September 16, 2026 discloses that Jens Holstein, a director of Veracyte, Inc. (NASDAQ:VCYT), sold 5,000 shares of common stock on September 14, 2026 under a pre-established Rule 10b5-1 trading plan.
Key Highlights
- Reporting person: Jens Holstein, identified as a Director of Veracyte, Inc.
- Transaction: 5,000 shares of common stock disposed of (transaction code S) on September 14, 2026.
- Weighted average price: $40.9494 per share, with individual sale prices ranging from $40.57 to $41.40.
- Remaining ownership: 27,471 shares of common stock beneficially owned directly following the transaction.
- 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 plan adopted by Holstein on June 12, 2026.
Details of Jens Holstein's September 2026 Share Disposition
According to the filing, Jens Holstein, a director at Veracyte, Inc., disposed of 5,000 shares of common stock on September 14, 2026. The transaction was coded "S," indicating a sale. The reported weighted average sales price was $40.9494 per share. The filing notes that "sale prices for the transactions range from $40.57 to $41.40" and that detailed information on the number of shares sold at each separate price is available to the SEC, the issuer, or a shareholder upon request.
The filing indicates that the transaction was carried out pursuant to a Rule 10b5-1 plan that Holstein adopted on June 12, 2026. The Form 4 also confirms that the checkbox indicating a transaction made pursuant to a contract, instruction, or written plan satisfying the affirmative defense conditions of Rule 10b5-1(c) was checked. Following the reported sale, Holstein directly holds 27,471 shares of Veracyte common stock, according to the filing. No derivative securities transactions were reported in Table II.
The Form 4 was signed by Jonathan Wygant as attorney-in-fact on September 16, 2026, the same date it was filed with the SEC.
What Was Disclosed
The filing reports a single open-market sale of 5,000 Veracyte common shares by director Jens Holstein on September 14, 2026, at a weighted average price of $40.9494, executed under a Rule 10b5-1 plan adopted June 12, 2026, leaving him with 27,471 shares held directly.



Please wait processing your request...